Diabetic Therapy
GLYJENTA M
Linagliptin 2.5 mg & Metformin 500 mg hydrochloride tablets
Dosage Form
Tablets
Packing
10*10 Blister
MRP
₹1599
Prescribed By
Diabetologist, Endocrinologist, General Physician, Internal Medicine, Family Medicine
Quick Facts
Form
Tablets
Pack
10×10 Blister
MRP
₹1599
Prescribed By
Diabetologist, Endocrinologist, General Physician
Key Benefits
01
Linagliptin is safe in kidney disease — no dose adjustment needed.
02
Combined with Metformin for dual-mechanism glucose control.
03
Low hypoglycaemia risk from Linagliptin's glucose-dependent action.
04
Convenient single tablet for step-up therapy.
Mechanism of Action
Linagliptin inhibits DPP-4 to increase insulin secretion in a glucose-dependent manner. Metformin reduces liver glucose production and improves insulin sensitivity. Two complementary mechanisms for balanced blood sugar control.
Indications
Type 2 diabetes mellitus inadequately controlled on Metformin alone.
Dosage & Administration
Take as prescribed by your doctor or healthcare professional. Do not self-medicate.
Why GLYJENTA M?
GLYJENTA M is particularly valuable for diabetic patients with kidney disease — Linagliptin requires no dose adjustment in renal impairment, making this combination safe across a broad patient population.
